In contrast, in the non-tumoral MCF10A cell line, treatment with CO-OCS was unable to alter the expression of STIM1 or Orai1, which indicates that protein glycosylation plays a relevant role in STIM1 expression and breast cancer cell migration [62]. This evidence concerns the gene ORAI1 and breast cancer.